Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Profound Medical (PROF) EBIT Margin (2019 - 2026)

Profound Medical has reported EBIT Margin over the past 7 years, most recently at 460.72% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 66055.0% year-over-year to 460.72%; the TTM value through Dec 2025 reached 39.43%, up 27878.0%, while the annual FY2025 figure was 39.43%, 27014.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 460.72% at Profound Medical, up from 168.52% in the prior quarter.
  • Over five years, EBIT Margin peaked at 1620.76% in Q4 2022 and troughed at 6838.5% in Q4 2023.
  • A 5-year average of 429.22% and a median of 271.43% in 2021 define the central range for EBIT Margin.
  • Biggest five-year swings in EBIT Margin: skyrocketed 671635bps in 2022 and later crashed -845927bps in 2023.
  • Year by year, EBIT Margin stood at 5095.59% in 2021, then surged by 132bps to 1620.76% in 2022, then tumbled by -522bps to 6838.5% in 2023, then surged by 97bps to 199.83% in 2024, then skyrocketed by 331bps to 460.72% in 2025.
  • Business Quant data shows EBIT Margin for PROF at 460.72% in Q4 2025, 168.52% in Q3 2025, and 624.42% in Q2 2025.